Perioperative oral nutritional support for patients diagnosed with primary colon adenocarcinoma undergoing radical surgical procedures -Peri-Nutri Trial: study protocol for a randomized controlled trial

Raila Aro, Pasi Ohtonen, Tero Rautio, Juha Saarnio, Elisa Mäkäräinen, Reetta Häivälä, Markus J Mäkinen, Anne Tuomisto, Ursula Schwab, Sanna Meriläinen, Raila Aro, Pasi Ohtonen, Tero Rautio, Juha Saarnio, Elisa Mäkäräinen, Reetta Häivälä, Markus J Mäkinen, Anne Tuomisto, Ursula Schwab, Sanna Meriläinen

Abstract

Background: Colon cancer is one of the most common cancers in Finland and worldwide. Cancer-related malnutrition is a well-known risk factor for increased morbidity and mortality after surgery, and it is associated with complications and longer hospitalizations. There are no established recommendations on how to improve the nutritional status of colon cancer patients´ during the perioperative phase. Administration of simple oral nutritional supplements has been suggested to reduce complication rates, but evidence to support this practice is scarce.

Methods: The Peri-Nutri trial is a prospective, multicenter, randomized, controlled trial. Its primary endpoint is to evaluate whether perioperative oral nutritional support (ONS) decreases the number of complications during the 30-day follow-up after surgery. Secondary endpoints are to study the effect of ONS on quality of life after surgery, length of stay in institutional care, 90-day mortality rate, five-year disease-free survival and overall survival. The patients with a Nutritional risk screening 2002 (NRS-2002) questionnaire result between 2 and 5 (≥ 3 are classified at risk of malnutrition) will be randomized (1:1 ratio) into either the intervention or control group. The intervention group will receive preoperative ONS two weeks before the operation, and nutritional support will continue 10 days after the operation. The control group will not receive ONS. A total of 318 patients will be randomized into two groups and patients are followed five years.

Discussion: Peri-Nutri study evaluate the impact of ONS to short-term and long-term postoperative morbidity and mortality rates of colon cancer patients undergoing curative surgery. If ONS will decrease patients´ morbidity and mortality, that has a huge impact on patients´ quality of life and also to financial cost.

Trial registration: ClinicalTrials.gov, NCT03863236 , Registered 25 February 2019.

Keywords: Colon cancer; Malnutrition; NRS-2002; Perioperative oral nutritional support; Randomized controlled trial.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Flowchart

References

    1. Finnish cancer registry. (Accessed 22 Jun 2021).
    1. Argilés JM. Cancer-associated malnutrition. Eur J Oncol Nurs 2005;9. 10.1016/j.ejon.2005.09.006.
    1. Shpata V, Prendushi X, Kreka M, Kola I, Kurti F, Ohri I. Malnutrition at the time of surgery affects negatively the clinical outcome of critically ill patients with gastrointestinal cancer. Med Arch 2014;68(4). 10.5455/medarh.2014.68.263-267.
    1. Santarpia L, Contaldo F, Pasanisi F. Nutritional screening and early treatment of malnutrition in cancer patients. J Cachexia Sarcopenia Muscle 2011;2(1). 10.1007/s13539-011-0022-x.
    1. Weimann A, et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr 2017;36(3). 10.1016/j.clnu.2017.02.013.
    1. Garth AK, Newsome CM, Simmance N, Crowe TC. Nutritional status, nutrition practices and post-operative complications in patients with gastrointestinal cancer. J Hum Nutr Diet 2010;23(4). 10.1111/j.1365-277X.2010.01058.x.
    1. Nishiyama VKG, Albertini SM, de Moraes CMZG, de Godoy MF, Netinho JG. Malnutrition and clinical outcomes in surgical patients with colorectal disease. Arq Gastroenterol 2018;55(4). 10.1590/s0004-2803.201800000-85.
    1. Schwegler I, von Holzen A, Gutzwiller JP, Schlumpf R, Mühlebach S, Stanga Z. Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. Br J Surg 2009;97(1). 10.1002/bjs.6805.
    1. Senesse P, et al. Nutritional support during oncologic treatment of patients with gastrointestinal cancer: Who could benefit? Cancer Treat Rev 2008;34(6). 10.1016/j.ctrv.2008.03.003.
    1. Gillis C, et al. Prehabilitation with whey protein supplementation on perioperative functional exercise capacity in patients undergoing colorectal resection for cancer: a pilot double-blinded randomized placebo-controlled trial. J Acad Nutr Diet 2016;116,(5). 10.1016/j.jand.2015.06.007.
    1. Burden ST, Hill J, Shaffer JL, Campbell M, Todd C. An unblinded randomised controlled trial of preoperative oral supplements in colorectal cancer patients. J Hum Nutr Diet 2011;24(5). 10.1111/j.1365-277X.2011.01188.x.
    1. MacFie J, Woodcock NP, Palmer MD, Walker A, Townsend S, Mitchell CJ. Oral dietary supplements in pre- and postoperative surgical patients: a prospective and randomized clinical tria. Nutrition 2000;16(9). 10.1016/S0899-9007(00)00377-4.
    1. Smedley F, et al. Randomized clinical trial of the effects of preoperative and postoperative oral nutritional supplements on clinical course and cost of care. Br J Surg 2004;91(8). 10.1002/bjs.4578.
    1. Kabata P, et al. Preoperative nutritional support in cancer patients with no clinical signs of malnutrition—prospective randomized controlled trial. Supportive Care Cancer 2015;23(2). 10.1007/s00520-014-2363-4.
    1. Yao H, Bian X, Mao L, Zi X, Yan X, Qiu Y. Preoperative enteral nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. Medicine 2015;94(46). 10.1097/MD.0000000000002006.
    1. Jie B, Jiang ZM, Nolan MT, Zhu SN, Yu K, Kondrup J. Impact of preoperative nutritional support on clinical outcome in abdominal surgical patients at nutritional risk. Nutrition 2012;28(10). 10.1016/j.nut.2012.01.017.
    1. Jie B et al. Impact of nutritional support on clinical outcome in patients at nutritional risk: a multicenter, prospective cohort study in Baltimore and Beijing teaching hospitals. Nutrition 2010;26(11–12). 10.1016/j.nut.2009.08.027
    1. Wu GH. Perioperative artificial nutrition in malnourished gastroin-testinal cancer patients. World J Gastroenterol 2006;12(15). 10.3748/wjg.v12.i15.2441.
    1. Chen Y. Nutrition support in surgical patients with colorectal cancer. World J Gastroenterol 2011;17(13). 10.3748/wjg.v17.i13.1779.
    1. Gillis C, et al. Effects of nutritional prehabilitation, with and without exercise, on outcomes of patients who undergo colorectal surgery: a systematic review and meta-analysis. Gastroenterology 2018;155(2). 10.1053/j.gastro.2018.05.012.
    1. Ravasco P, Monteiro-Grillo I, Camilo M. Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy. Am J Clin Nutr 2012;96(6). 10.3945/ajcn.111.018838.
    1. Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 2005;23(7). 10.1200/JCO.2005.02.054.
    1. Burden S, Todd C, Hill J, Lal S. Pre-operative nutrition support in patients undergoing gastrointestinal surgery. Cochrane Database Syst Rev 2012. 10.1002/14651858.CD008879.pub2.
    1. Aro A, Mutanen M, Uusitupa M (eds). Ravitsemustiede. 2., uudistettu painos edn. Helsinki: Kustannus Oy Duodecim; 2005.
    1. Kondrup J. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003;22(3). 10.1016/S0261-5614(02)00214-5.
    1. Grundmann O, Yoon SL, Williams JJ. The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients—a comprehensive review. Eur J Clin Nutr 2015;69(12). 10.1038/ejcn.2015.126.
    1. Aleixo GFP, Shachar SS, Nyrop KA, Muss HB, Battaglini CL, Williams GR. Bioelectrical impedance analysis for the assessment of sarcopenia in patients with cancer: a systematic review. Oncologist 2020;25(2). 10.1634/theoncologist.2019-0600.
    1. Kyle UG, et al. Bioelectrical impedance analysis—part II: utilization in clinical practice. Clin Nutr 2004;23(6). 10.1016/j.clnu.2004.09.012.
    1. Kyle U. Bioelectrical impedance analysis? part I: review of principles and methods. Clin Nutr 2004;23(5). 10.1016/j.clnu.2004.06.004.
    1. Matos LC, Tavares MM, Amaral TF. Handgrip strength as a hospital admission nutritional risk screening method. Eur J Clin Nutr 2007;61(9).10.1038/sj.ejcn.1602627.
    1. Orell-Kotikangas H, Österlund P, Saarilahti K, Ravasco P, Schwab U, Mäkitie AA. NRS-2002 for pre-treatment nutritional risk screening and nutritional status assessment in head and neck cancer patients. Supportive Care Cancer 2015;23(6). 10.1007/s00520-014-2500-0.
    1. Cooper R, Kuh D, Hardy R, Mortality Review Group. Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ 2010;341. 10.1136/bmj.c4467.
    1. Omran ML, Morley JE. Assessment of protein energy malnutrition in older persons, part II: laboratory evaluation. Nutrition 2000;16(2). 10.1016/S0899-9007(99)00251-8.
    1. Mourtzakis M, Prado CMM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008;33(5). 10.1139/H08-075.
    1. van Vugt JLA, et al. Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer. Eur J Surg Oncol. 2018;44(9):1354–1360. doi: 10.1016/j.ejso.2018.05.029.
    1. Klintrup K, et al. Inflammation and prognosis in colorectal cancer. Eur J Cancer 2005;41(17). 10.1016/j.ejca.2005.07.017.
    1. Väyrynen JP, et al. Characteristics and significance of colorectal cancer associated lymphoid reaction. Int J Cancer 2014;134(9). 10.1002/ijc.28533.
    1. Hays RD, Sherbourne CD, Mazel RM. The rand 36-item health survey 1.0. Health Econ. 1993;2(3):217–227. doi: 10.1002/hec.4730020305.
    1. Zhang J, Yu KF. What’s the Relative Risk? JAMA 1998;280(19). 10.1001/jama.280.19.1690.
    1. Arends J, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr 2017;36(1). 10.1016/j.clnu.2016.07.015.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться